The Inspirational Quest to Eradicate Cancer

The world-renowned Thoracic Oncologist, Dr. Gerold Bepler, joined I Don’t Care’s Kevin Stevenson for a conversation that was no less than inspirational. Dr. Bepler, President and CEO of the Karmanos Cancer Institute, has a mission; to eradicate cancer. It’s more than a dream for Dr. Bepler; he believes it will be a reality one day.

Dr. Bepler arrived from Germany to the United States in 1983. Following a post-doctoral fellowship at the National Cancer Institute, the starting point for his journey into lung cancer research. This career path took Dr. Bepler through many stops along the way, and in 2010 he joined the Karmanos Cancer Institute.

The mission to eradicate cancer got a boost in 1971 with the National Cancer Act, and Dr. Bepler said there’s tremendous progress towards this goal since that point. “People now diagnosed with cancer have hope,” Dr. Bepler said. “And many of them get cured of the disease and have a good quality of life. That all wouldn’t have been possible without the National Cancer Act.”

Much of the progress made to eradicating cancer at the Karmanos Cancer Institute owes a debt of gratitude to that 50-year-old law for providing necessary funding that makes such research possible.

“The Karmanos Cancer Institute became one of the NCI designated cancer centers,” Dr. Bepler said. “Very quickly, the National Cancer Institute realized just having one cancer institute in Bethesda, Maryland alone wouldn’t be able to achieve that high goal of eradicating cancer. This network established cancer centers throughout the United States.” What started as a couple of centers in the 1970s is now more than 50 comprehensive cancer centers.

The world now possesses many drugs and treatments to treat cancer through the dedication and research of institutes like the Karmanos Center. And some research led to treatments for other diseases. Dr. Bepler mentioned the Karmanos Center developed three of the first FDA-approved AIDS drugs.

More Like This Story:

The Rising Tide of Food Allergens

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Follow us on social media for the latest updates in B2B!



Puerto Rican history
Restoring Puerto Rican History After Hurricane Maria
July 25, 2024

Polygon document recovery solutions were put to the test after Hurricane Maria in 2017. Puerto Rican history was at stake from damage to the Instituto de Cultura Peurtorriqueña building, causing leaks, humidity, and mold. Polygon’s document recovery center received nearly 2,000 boxes of documents from Puerto Rico in 2023. These valuable pieces of Puerto…

Read More
document recovery
Document Recovery Chamber: Inside Polygon’s Advanced Vacuum Freeze-Dry Process
July 25, 2024

Join Chris Chylack, District Manager at Polygon U.S., as he provides an insightful tour of their advanced vacuum freeze-dry process at the Allentown, Pennsylvania, Document Recovery Center. This state-of-the-art procedure begins by stabilizing water-damaged materials in blast freezers, preventing further degradation. The materials are then subjected to a sublimation process in a specialized chamber,…

Read More
managing humidity
Managing Humidity in a NCAA Ice Rink
July 25, 2024

Indoor ice rinks, crucial for sports and recreation, often face challenges managing humidity, leading to condensation and fog. These issues arise from factors like spectator presence, inadequate ventilation, and temperature variations, impacting playability and revenue. A case study at a NCAA Division 1 rink in Massachusetts highlighted how failing air handlers jeopardized operations just…

Read More
MedPAC’s Miss on Reality of Home Health Financial Reality Results in Suggested Cut in 2025 Proposed Rule
July 24, 2024

The March 2024 MedPAC report recommending a 7% payment reduction for home health agencies in 2025 has sparked significant concern within the industry. Why is this recommendation being met with such resistance, and what does the financial reality of home health agencies look like in contrast to these federal suggestions? Are the MedPAC recommendations…

Read More